Nav: Home

Deprivation associated with increased risk of death following hospital admission with type 2 diabetes

September 17, 2019

New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept) shows that where you live has an impact on how likely you are to die for patients with type 2 diabetes (T2D), and how likely you are to be readmitted to hospital for patients with type 1 diabetes (T1D) following hospital discharge. The study is by Dr Tim Robbins, Institute of Digital Healthcare, WMG, University of Warwick, Coventry, UK, and colleagues from both the University of Warwick and University Hospitals Coventry & Warwickshire NHS Trust, UK.

Patients with diabetes face an increased risk of negative outcomes following hospital discharge, regardless of their reason for admission. In addition, socioeconomic factors are known to drive poor health outcomes in people with diabetes generally. Despite this, there has been little research done to assess the impact of socioeconomic factors on health outcomes when patients with diabetes are discharged from hospital. This has mainly been due to the difficulty of linking the various datasets required to get a complete picture of the health outcomes and socioeconomic statuses of these patients.

This new study was based on a retrospective evaluation of data from the electronic health records (EHR) of a large UK specialist referral centre (University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK) and included all adult patients discharged with a diabetes diagnosis over a 3-year period. These comprised 46,357 distinct discharges and were matched at a patient level with postcode sector socioeconomic data extracted from the Office of National Statistics Census and Population Density datasets.

Information on 19 socioeconomic variables was available including index of multiple deprivation, employment status, ethnicity, activity levels, unpaid care provision, and density of population and housing, which could then be used to determine the socioeconomic status of each patient. The clinical outcome measures chosen were readmission within 28 days, and incidence of mortality within 180 days (approximately six months) of discharge from hospital.

The authors found that socioeconomic status measured by 14 of the 19 variables was significantly associated with 180-day mortality in the T2D patient cohort, while in the T1D cohort they found no statistically significant association between mortality and socioeconomic variables. Among T2D patients, the strongest links with mortality were found to be language (non-English), ethnicity (ethnic minorities), and index of multiple deprivation.

For hospital readmissions, only 1 of the 19 variables showed a significant association in T2DM patients, compared to 9 statistically significant variables in the T1DM group, with the strongest being deprivation indices and health-related activity impairment.

The authors say: "There is a strong association between geographic socioeconomic status and readmission to hospital in patients with type 1 diabetes, but no clear link with mortality. In contrast in patients with type 2 diabetes, mortality is strongly associated with socioeconomic status whilst readmission to hospital is not. In summary, where you live has an impact on how likely you are to be readmitted to hospital for patients with type 1 diabetes, and how likely you are to die for patients with type 2 diabetes following hospital discharge."

They add: "Use of geographic postcode sector data can be readily incorporated into electronic healthcare systems and future risk models to enable personalised data-driven care, for example more intensive, or different models, or more intensive follow up for those from areas of known deprivation."

Dr Tim Robbins is following up on this research through a prestigious European Foundation for the Study of Diabetes (EFSD) Albert Renold Travel Fellowship, looking at digital approaches to diabetes integrated care, in the Basque County, Spain. EFSD has been created by EASD to stimulate diabetes research in Europe.


Related Diabetes Articles:

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 1: Numbers
In a recent Radiolab group huddle, with coronavirus unraveling around us, the team found themselves grappling with all the numbers connected to COVID-19. Our new found 6 foot bubbles of personal space. Three percent mortality rate (or 1, or 2, or 4). 7,000 cases (now, much much more). So in the wake of that meeting, we reflect on the onslaught of numbers - what they reveal, and what they hide.  Support Radiolab today at